Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs
The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.
FDA announces recall on insulin pump pods after leaks cause 29 serious injuries
Some Omnipod 5 devices, manufactured by Insulet, are subject to the Class I recall. The products with the defect must be removed from where they are used or sold to ensure safety, as lower-than-expected insulin doses could have potentially lethal repercussions.
5-point call goes out for action against ‘one of the most urgent and complex socioeconomic challenges of our time’
U.S. healthcare is in the throes of an affordability crisis. The good news is that healthcare leaders have all the evidence, tools and expertise needed to keep the predicament from becoming a plight. Can they marshal the will to wield those weapons toward that end?
Heart Rhythm 2026: Electrophysiologist Mina Chung discusses CPR, PFA and much more
Mina Chung, MD, who just concluded a one-year term as Heart Rhythm Society's president, spoke to Cardiovascular Business about successes from the past year as well as her goals for the future.
Overheard on Capitol Hill: Hospital leaders getting upbraided over ‘charging an insane amount for care’
A handful of health-system CEOs took withering fire this week at a hearing of the House Ways and Means Committee.

overweight patient seeking health advice

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs

The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.

FDA recall medical device recall product recall

FDA announces recall on insulin pump pods after leaks cause 29 serious injuries

Some Omnipod 5 devices, manufactured by Insulet, are subject to the Class I recall. The products with the defect must be removed from where they are used or sold to ensure safety, as lower-than-expected insulin doses could have potentially lethal repercussions.

doctor comparing the costs of different medical treatments

5-point call goes out for action against ‘one of the most urgent and complex socioeconomic challenges of our time’

U.S. healthcare is in the throes of an affordability crisis. The good news is that healthcare leaders have all the evidence, tools and expertise needed to keep the predicament from becoming a plight. Can they marshal the will to wield those weapons toward that end?

HRS President, Mina Chung, MD, FHRS, staff cardiologist and Professor of Medicine in the Section of Pacing and Electrophysiology, Heart & Vascular Institute, Cleveland Clinic. Explains HRS accomplishments in the past year in terms of advocacy efforts and policy concerns impacting EP. #HRS2026 #EPeeps

Heart Rhythm 2026: Electrophysiologist Mina Chung discusses CPR, PFA and much more

Mina Chung, MD, who just concluded a one-year term as Heart Rhythm Society's president, spoke to Cardiovascular Business about successes from the past year as well as her goals for the future.

Overheard on Capitol Hill: Hospital leaders getting upbraided over ‘charging an insane amount for care’

A handful of health-system CEOs took withering fire this week at a hearing of the House Ways and Means Committee.

breast radiologist breast cancer mammography

Nearly half of women surveyed still think breast cancer screening starts at 50

The responses also suggested that a significant amount of women believe mammograms start before 40, highlighting a gap in screening policy knowledge.

FDA approves next-gen mitral valve from Medtronic

The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access.

healthcare surprise billing statement payment

Radiologists implore HHS to punish payers who undermine surprise-billing protections

Over 100 specialty societies and state medical associations wrote to Health and Human Services and other departments to voice their growing frustration with the No Surprises Act.